FDA Investment to Support NIPTE's Drug Programmes

The investment up to $35 million over the next five years will support programmes to rectify drug development and manufacturing problems to improve drug manufacturing standards in the US.

The National Institute for Pharmaceutical Technology will receive a grant of up to $35 million over the next five years from the US FDA to improve drug manufacturing standards in the US.

The grant will be spent on the research of drug development in the hope of decreased manufacturing costs and improving the safety of drugs. The investment will also help reverse the current outsourcing trends in the pharmaceutical industry by improving the US' manufacturing competitiveness.

The investment will support programmes to rectify drug development and manufacturing problems, by creating ways to reduce time to market, enabling new performance attributes, improving small-batch production or saving money and energy.

&n